i started semaglutide at 52 Semaglutide: A Weight Loss Breakthrough A 52-year-old woman said the

GLP-1 Drugs and Brain Health: Can They Reduce Alzheimers Risk

NICE guideline NG28 for type 2 diabetes recommends GLP-1 therapy for patients with inadequate glycaemic control despite optimal management with other glucose-lowering medications, and particularly for those who would benefit from weight loss

The GLP-1 plotter is a useful tracking tool for visualizing your dose progression and weight trend over time

The balance between copper and zinc is essential for the proper functioning of metallothionein and ceruloplasmin

Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota